ɪn tˈuː θˈaʊzənd twˈɛnti hiː kˈoʊfˈaʊndᵻd fˈaɪlɛks bˈaɪoʊ sˈaɪənsᵻz, ˈɪŋk., ɐ kˈʌmpəni bˈeɪst ɪn sˌæn dɪˈeɪɡoʊ dɪvˈɛləpɪŋ ɐ jˌuːnɪvˈɜːsəl væksˈiːn ɐɡˈɛnst ðə sᵻvˈɪɹ ɐkjˈuːt ɹˈɛspɹətˌoːɹi sˈɪndɹoʊm kˈɔːɹənˌævaɪɹəs tˈuː sˈɑːɹzkˈoʊ vˈiː tˈuː.
In 2020 he co-founded Phylex BioSciences, Inc., a company based in San Diego developing a universal vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).